| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0021368> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0023884> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0023895> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0086565> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C0960880> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C5200801> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33771662_HAS_TOPIC_C5433525>
?:authorAffiliation	[\'Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium. Electronic address: mathieu.vinken@vub.be.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Vinken_Mathieu>
?:doi	<https://research.tib.eu/covid-19/entity/S0300-483X%2821%2900088-310.1016/j.tox.2021.152765>
?:doi	S0300-483X(21)00088-310.1016/j.tox.2021.152765
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Toxicology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33771662>
?:pmid	<https://research.tib.eu/covid-19/entity/33771662>
?:pmid	33771662
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.1
?:rankingScore_hIndex	137
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0021368_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0242184_PROCESS_OF_C0030705>
?:title	COVID-19 and the liver: an adverse outcome pathway perspective.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33771662>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33771662>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all